More Abuse

It is extremely difficult for a foreign scientist to obtain tenure-track positions. I know at least 50 so-called foreign scientists who have been in this country for more than 10 years and none of them have a tenure-track position. Many of them (including myself) has written grants independently but were required to put someone s name as a principal investigator in order to continue the employment. Almost all of these scientists have excellent track records. I have published several papers (

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It is extremely difficult for a foreign scientist to obtain tenure-track positions. I know at least 50 so-called foreign scientists who have been in this country for more than 10 years and none of them have a tenure-track position. Many of them (including myself) has written grants independently but were required to put someone s name as a principal investigator in order to continue the employment. Almost all of these scientists have excellent track records.

I have published several papers (including invited review articles) in top-quality journals and have obtained NIH grants (as a principal investigator) as well as a Research Career Development Award. I also have an excellent teaching record; each year, students rate me as one of the best teachers at one of the top-ranked universities in the U.S. Still I am unable to find a tenure-track position. Yet others with less than outstanding records get such positions. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies